Resultados de procura - Westhoff, Mike-Andrew
- Mostrando 1 - 20 Resultados de 55
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Cerebral Microstructural Alterations after Radiation Therapy in High-Grade Glioma: A Diffusion Tensor Imaging-Based Study por Kassubek, Rebecca, Gorges, Martin, Westhoff, Mike-Andrew, Ludolph, Albert C., Kassubek, Jan, Müller, Hans-Peter
Publicado 2017Text -
8
-
9
Epigenetic Targeting of Mcl-1 Is Synthetically Lethal with Bcl-xL/Bcl-2 Inhibition in Model Systems of Glioblastoma por Shang, Enyuan, Nguyen, Trang T. T., Shu, Chang, Westhoff, Mike-Andrew, Karpel-Massler, Georg, Siegelin, Markus D.
Publicado 2020Text -
10
Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells por Burster, Timo, Traut, Rebecca, Yermekkyzy, Zhanerke, Mayer, Katja, Westhoff, Mike-Andrew, Bischof, Joachim, Knippschild, Uwe
Publicado 2021Text -
11
Comment in Response to “Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy etc. by B. Kaina” por Westhoff, Mike-Andrew, Baisch, Tim, Herbener, Verena J., Karpel-Massler, Georg, Debatin, Klaus-Michael, Strobel, Hannah
Publicado 2020Text -
12
EXTH-64. IMIPRIDONES CAUSE METABOLIC REPROGRAMMING AND ELICIT UNIQUE VULNERABILITIES IN PRECLINICAL MODEL SYSTEMS OF GLIOBLASTOMA por Ishida, Chiaki, Zhang, Yiru, Westhoff, Mike-Andrew, Karpel-Massler, Georg, Prabhu, Varun Vijay, Allen, Joshua, Siegelin, Markus
Publicado 2018Text -
13
EXTH-68. DUAL METABOLIC REPROGRAMMING BY ONC201/TIC10 AND 2-DEOXYGLUCOSE HAS A STRONG ANTIPROLIFERATIVE EFFECT ON MEDULLOBLASTOMA CELLS por Dwucet, Annika, Cao, Qiyu, Pruss, Maximilian, Westhoff, Mike-Andrew, Wirtz, Christian Rainer, Siegelin, Markus D, Karpel-Massler, Georg
Publicado 2021Text -
14
Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma por Westhoff, Mike-Andrew, Faham, Najmeh, Marx, Daniela, Nonnenmacher, Lisa, Jennewein, Claudia, Enzenmüller, Stefanie, Gonzalez, Patrick, Fulda, Simone, Debatin, Klaus-Michael
Publicado 2013Text -
15
Mitochondrial matrix chaperone and c-myc inhibition causes enhanced lethality in glioblastoma por Ishida, Chiaki Tsuge, Shu, Chang, Halatsch, Marc-Eric, Westhoff, Mike-Andrew, Altieri, Dario C., Karpel-Massler, Georg, Siegelin, Markus David
Publicado 2017Text -
16
Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems por Shang, Enyuan, Zhang, Yiru, Shu, Chang, Ishida, Chiaki Tsuge, Bianchetti, Elena, Westhoff, Mike-Andrew, Karpel-Massler, Georg, Siegelin, Markus D.
Publicado 2018Text -
17
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy por Strobel, Hannah, Baisch, Tim, Fitzel, Rahel, Schilberg, Katharina, Siegelin, Markus D., Karpel-Massler, Georg, Debatin, Klaus-Michael, Westhoff, Mike-Andrew
Publicado 2019Text -
18
Inhibition of HDAC1/2 Along with TRAP1 Causes Synthetic Lethality in Glioblastoma Model Systems por Nguyen, Trang T. T., Zhang, Yiru, Shang, Enyuan, Shu, Chang, Quinzii, Catarina M., Westhoff, Mike-Andrew, Karpel-Massler, Georg, Siegelin, Markus D.
Publicado 2020Text -
19
Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo por Karpel-Massler, Georg, Ramani, Doruntina, Shu, Chang, Halatsch, Marc-Eric, Westhoff, Mike-Andrew, Bruce, Jeffrey N., Canoll, Peter, Siegelin, Markus D.
Publicado 2016Text -
20
CBMT-35. METABOLIC REWIRING BY ONC201/TIC10 AND 2-DEOXYGLUCOSE HAS SYNERGISTIC ANTI-GLIOBLASTOMA ACTIVITY por Pruss, Maximilian, Dwucet, Annika, Hlavac, Michal, Kast, Richard, Westhoff, Mike-Andrew, Wirtz, Rainer, Halatsch, Marc-Eric, Siegelin, Markus, Karpel-Massler, Georg
Publicado 2019Text